Saccharomyces cerevisiae Antibody, IgG
Saccharomyces cerevisiae is a yeast widely used in the baking and brewing industries. In certain autoimmune and inflammatory conditions, this yeast is recognized by the immune system and leads to the production of antibodies known as anti-Saccharomyces cerevisiae antibodies (ASCA), which may be of IgA or IgG type.
ASCA has diagnostic relevance in inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gastrointestinal tract that includes ulcerative colitis and Crohn disease. While IBD can be distinguished from non-inflammatory gastrointestinal conditions using fecal calprotectin, differentiating ulcerative colitis from Crohn disease based on clinical presentation can be difficult.
Although, serologic testing for ASCA antibody is not specific, it can assist in subtyping IBD. Patients with ulcerative colitis frequently test positive for perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) and are typically ASCA-negative, whereas patients with Crohn disease are more likely to test positive for ASCA (IgA and/or IgG) and are often pANCA-negative.
Although ASCA testing provides useful supportive information, it is not a definitive diagnostic test and should be interpreted in conjunction with clinical, endoscopic, histologic, and radiographic findings.
- As an aid in differential diagnosis of ulcerative colitis and Crohn disease
- As an aid in the diagnosis of inflammatory bowel disease
The presence of ASCA (IgA and/or IgG) with absence of ANCA is suggestive of Crohn’s disease.
The absence of ASCA with presence of ANCA is more consistent with ulcerative colitis. Isolated ASCA positivity is not diagnostic of IBD and should not be used alone for clinical decision-making.
False positives may occur in celiac disease, autoimmune hepatitis, and healthy individuals.
Negative: <20.0 RU/mL
Positive: > or = 20.0 RU/mL
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum, SST.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- Inflamm Bowel Dis. 2001;7:192–201. [PMID: 11515844]
- Lancet. 2017 Apr 29;389(10080):1741-1755. [PMID: 27914655]
- J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):82-87. [PMID: 30789863]
- Clin Exp Immunol. 2003 Jun;132(3):473-6. [PMID: 12780695]
- Clin Exp Immunol. 2004 Mar;135(3):490-6. [PMID: 15008984]
- Inflamm Bowel Dis. 2003 Sep;9(5):324-31. [PMID: 14555917]
- Gut. 2005 Sep;54(9):1232-6. [PMID: 16099791]